Cushings Syndrome: Important Issues in Diagnosis and Management
James W. Findling and
Hershel Raff
Endocrine-Diabetes Center (J.W.F.) and Endocrine Research Laboratory (H.R.), St. Lukes Medical Center, Milwaukee, Wisconsin 53215; and Department of Medicine (J.W.F., H.R.), Medical College of Wisconsin, Milwaukee, Wisconsin 53226
Address all correspondence and requests for reprints to: Hershel Raff, Ph.D., Endocrinology, St. Lukes Physicians Office Building, 2801 West KK River Parkway, Suite 245, Milwaukee, Wisconsin 53215. E-mail: hraff{at}mcw.edu.
Context: The diagnosis, differential diagnosis, and treatmentof Cushings syndrome are challenging problems in clinicalendocrinology. We focus on critical questions addressing screeningfor Cushings syndrome, differentiation of Cushingssubtypes, and treatment options.
Evidence Acquisition: Ovids MEDLINE (1996 through April2006) was used to search the general literature. We also reliedon previously published reviews and a recent monograph and citea mix of primary articles and recent reviews.
Evidence Synthesis: Although this article represents our opinion,it draws heavily on a recent consensus statement from expertsin the field and a recent monograph on Cushings syndrome.
Conclusions: We concluded that: 1) measurement of late-nightor bedtime salivary cortisol is a useful approach to screenfor Cushings syndrome; 2) measurement of suppressed plasmaACTH by immunometric assay is useful to differentiate ACTH-dependentand -independent Cushings syndrome; 3) inferior petrosalsinus sampling for ACTH should be performed in patients withACTH-dependent hypercortisolism in whom a pituitary magneticresonance imaging is normal or equivocal (in the absence ofa pituitary ACTH gradient, prolactin levels should be measuredto confirm the integrity of venous sampling); 4) computed tomographyof the chest and abdomen and somatostatin receptor scintigraphyshould be performed in patients with the occult ectopic ACTHsyndrome; and 5) patients with Cushings disease shouldbe referred to a neurosurgeon with extensive experience operatingon corticotroph microadenomas. Bilateral laparoscopic adrenalectomyshould be considered in patients with Cushings diseasewho fail therapies directed at the pituitary.
This article has been cited by other articles:
E. Valassi, B. Swearingen, H. Lee, L. B. Nachtigall, D. A. Donoho, A. Klibanski, and B. M. K. Biller Concomitant Medication Use Can Confound Interpretation of the Combined Dexamethasone-Corticotropin Releasing Hormone Test in Cushing's Syndrome
J. Clin. Endocrinol. Metab.,
December 1, 2009;
94(12):
4851 - 4859.
[Abstract][Full Text][PDF]
A. Takeshita, N. Inoshita, M. Taguchi, C. Okuda, N. Fukuhara, K. Oyama, K. Ohashi, T. Sano, Y. Takeuchi, and S. Yamada High incidence of low O6-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease
Eur. J. Endocrinol.,
October 1, 2009;
161(4):
553 - 559.
[Abstract][Full Text][PDF]
H. Raff Utility of Salivary Cortisol Measurements in Cushing's Syndrome and Adrenal Insufficiency
J. Clin. Endocrinol. Metab.,
October 1, 2009;
94(10):
3647 - 3655.
[Abstract][Full Text][PDF]
M. Boscaro and G. Arnaldi Approach to the Patient with Possible Cushing's Syndrome
J. Clin. Endocrinol. Metab.,
September 1, 2009;
94(9):
3121 - 3131.
[Abstract][Full Text][PDF]
P. Wood Salivary steroid assays - research or routine?
Ann Clin Biochem,
May 1, 2009;
46(3):
183 - 196.
[Abstract][Full Text][PDF]
A. C Heijboer, F. Martens, and M. A Blankenstein Measuring salivary cortisol with the Architect i2000 random access analyser
Ann Clin Biochem,
May 1, 2009;
46(3):
261 - 262.
[Full Text][PDF]
B. Masserini, V. Morelli, S. Bergamaschi, F. Ermetici, C. Eller-Vainicher, A. M. Barbieri, M. A. Maffini, A. Scillitani, B. Ambrosi, P. Beck-Peccoz, et al. The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma
Eur. J. Endocrinol.,
January 1, 2009;
160(1):
87 - 92.
[Abstract][Full Text][PDF]
S. Jehle, J. E. Walsh, P. U. Freda, and K. D. Post Selective Use of Bilateral Inferior Petrosal Sinus Sampling in Patients with Adrenocorticotropin-Dependent Cushing's Syndrome Prior to Transsphenoidal Surgery
J. Clin. Endocrinol. Metab.,
December 1, 2008;
93(12):
4624 - 4632.
[Abstract][Full Text][PDF]
E. Singer, S. Strohm, U. Gobel, M. Bieringer, D. Schmidt, W. Schneider, R. Kettritz, and F. C. Luft Cushing's Disease, Hypertension, and Other Sequels
Hypertension,
December 1, 2008;
52(6):
1001 - 1005.
[Full Text][PDF]
P. Burman, A. Lethagen, K. Ivancev, L. Johansson, and A. Sundin Dual bronchial carcinoids and Cushing's syndrome with a paradoxical response to dexamethasone and a false positive outcome of inferior petrosal sinus sampling
Eur. J. Endocrinol.,
October 1, 2008;
159(4):
483 - 488.
[Abstract][Full Text][PDF]
J. Moreno-Fernandez, C. Gutierrez-Alcantara, M. A. Galvez Moreno, L. Jimenez-Reina, J. P. Castano, and P. Benito-Lopez Corticotrophin-Dependent Cushing Syndrome Due to Sacrococcygeal Teratoma Detected by [18F]Fluorodeoxyglucose Positron Emission Tomography
J. Clin. Endocrinol. Metab.,
September 1, 2008;
93(9):
3282 - 3283.
[Full Text][PDF]
L. Wood, D. H Ducroq, H. L Fraser, S. Gillingwater, C. Evans, A. J Pickett, D. W Rees, R. John, and A. Turkes Measurement of urinary free cortisol by tandem mass spectrometry and comparison with results obtained by gas chromatography-mass spectrometry and two commercial immunoassays
Ann Clin Biochem,
July 1, 2008;
45(4):
380 - 388.
[Abstract][Full Text][PDF]
B. M. K. Biller, A. B. Grossman, P. M. Stewart, S. Melmed, X. Bertagna, J. Bertherat, M. Buchfelder, A. Colao, A. R. Hermus, L. J. Hofland, et al. Treatment of Adrenocorticotropin-Dependent Cushing's Syndrome: A Consensus Statement
J. Clin. Endocrinol. Metab.,
July 1, 2008;
93(7):
2454 - 2462.
[Abstract][Full Text][PDF]
P. C. Myhill, B. A. Sillars, S. Starkstein, T. Annus, and B. B. Yeap Reduction in Salivary Cortisol Concentration Correlates with Resolution of Psychosis in Cushing's Syndrome
J Neuropsychiatry Clin Neurosci,
February 1, 2008;
20(1):
113 - 115.
[Full Text][PDF]
S. Kidambi, H. Raff, and J. W Findling Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome
Eur. J. Endocrinol.,
December 1, 2007;
157(6):
725 - 731.
[Abstract][Full Text][PDF]
S. K. Baid, N. Sinaii, M. Wade, D. Rubino, and L. K. Nieman Radioimmunoassay and Tandem Mass Spectrometry Measurement of Bedtime Salivary Cortisol Levels: A Comparison of Assays to Establish Hypercortisolism
J. Clin. Endocrinol. Metab.,
August 1, 2007;
92(8):
3102 - 3107.
[Abstract][Full Text][PDF]
Authors/Task Force Members:, G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, G. Grassi, A. M. Heagerty, S. E. Kjeldsen, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Eur. Heart J.,
June 11, 2007;
(2007)
ehm236v1.
[Full Text][PDF]
S. Tsagarakis, D. Vassiliadi, I. S. Kaskarelis, J. Komninos, E. Souvatzoglou, and N. Thalassinos The Application of the Combined Corticotropin-Releasing Hormone plus Desmopressin Stimulation during Petrosal Sinus Sampling Is Both Sensitive and Specific in Differentiating Patients with Cushing's Disease from Patients with the Occult Ectopic Adrenocorticotropin Syndrome
J. Clin. Endocrinol. Metab.,
June 1, 2007;
92(6):
2080 - 2086.
[Abstract][Full Text][PDF]